Bill Anderson became CEO in 2023, and one of his commitments was to get the glyphosate litigation “under control” by the end ...

A study from 2000, which concluded the herbicide glyphosate was safe for humans, has just been retracted, after documents ...

“The retracted review has been read by many scientists over 25-years and cited in 1,311 scientific papers. It is likely that the evidence and views presented in the retracted paper have had a ...

A controversial scientific paper that claimed the weed killer glyphosate (brand name Roundup) "does not pose a health risk to ...

A paper purportedly demonstrating the safety of glyphosate that has historically been “a cornerstone in the assessment of ...

The retraction of the glyphosate safety report comes as the Trump admin throws support behind Roundup lawsuit appeal.

Bayer stock may offer upside despite litigation and debt risks. Learn how recent developments could unlock value for BAYZF ...

The 2000 study in the scientific journal Regulatory Toxicology and Pharmacology had concluded that the active ingredient in Roundup, glyphosate, did not pose a cancer risk to humans.

A 2000 study that concluded the well-known herbicide glyphosate was safe, widely cited since then, has just been officially ...

The authors didn’t disclose financial compensation they received from Monsanto for their work on a ghostwritten paper about the herbicide’s safety ...

The U.S. patent validates a biological approach to degrading glyphosate as pressure grows around herbicide safety and regulation.

The glyphosate shortage that started the spring of 2021 is only intensifying as farmers prepare for the 2022 growing season. However, as growers try to source enough of the widely used herbicide for ...